Population Pharmacokinetic Analysis of DS-8201a, A HER2-Targeting Antibody-Drug Conjugate, in Patients with HER2-Positive Breast Cancer or Other Solid Tumors Poster Population Pharmacokinetic Analysis of DS-8201a, A HER2-Targeting Antibody-Drug Conjugate, in Patients with HER2-Positive Breast Cancer or Other Solid Tumors Danielle Pillsbury2019 年 5 月 2 日
Simulating the Impact of the Interplay Between CYP2C19 Polymorphisms and Ethnicity on Response to Clopidogrel, Using PBPK-PD Models Poster Simulating the Impact of the Interplay Between CYP2C19 Polymorphisms and Ethnicity on Response to Clopidogrel, Using PBPK-PD Models Danielle Pillsbury2019 年 4 月 22 日
Exposure-Response Analyses to Support Dose Justification of DS-8201A, A HER2-Targeting Antibody-Drug Conjugate, in HER2-Positive Breast Cancer Patients Poster Exposure-Response Analyses to Support Dose Justification of DS-8201A, A HER2-Targeting Antibody-Drug Conjugate, in HER2-Positive Breast Cancer Patients Danielle Pillsbury2019 年 4 月 22 日
Relationship of Ivosidenib Plasma Concentration to Heart Rate-Corrected QT Interval in Patients with IDH1-Mutant Advanced Hematologic Malignancies Poster Relationship of Ivosidenib Plasma Concentration to Heart Rate-Corrected QT Interval in Patients with IDH1-Mutant Advanced Hematologic Malignancies Danielle Pillsbury2019 年 4 月 22 日
Validation of the Pharmacokinetic/Pharmacodynamic Model Used for Dose Selection of Andexanet Alfa for Reversal of Anticoagulation Poster Validation of the Pharmacokinetic/Pharmacodynamic Model Used for Dose Selection of Andexanet Alfa for Reversal of Anticoagulation Danielle Pillsbury2019 年 4 月 22 日
How to Perform IVIVC for Extremely Long Acting Drugs On-Demand Webinar How to Perform IVIVC for Extremely Long Acting Drugs Watch this webinar to learn how to use in vitro and in vivo models to…Danielle Pillsbury2019 年 2 月 22 日
Automated Average Bioequivalence Analysis with Additional Metrics and Statistics to Meet the FDA Guidance on Methylphenidate Hydrochloride Using Phoenix WinNonlin Poster Automated Average Bioequivalence Analysis with Additional Metrics and Statistics to Meet the FDA Guidance on Methylphenidate Hydrochloride Using Phoenix WinNonlin Danielle Pillsbury2018 年 11 月 4 日
How to Use a Reference-scaled Average Bioequivalence Approach for Narrow Therapeutic Index Drugs On-Demand Webinar How to Use a Reference-scaled Average Bioequivalence Approach for Narrow Therapeutic Index Drugs Watch this webinar to learn how RSABE for NTIDs can be performed in Phoenix WinNonlin…Danielle Pillsbury2018 年 9 月 25 日
Certara Professional Certification Program Brochure Certara 专业认证计划 Certara Professional Certification is an online accreditation of user competency and proficiency in analysis of…Danielle Pillsbury2018 年 8 月 21 日
Using IVIVC to Optimize Your Drug Formulation After a Failed BA/BE Study On-Demand Webinar Using IVIVC to Optimize Your Drug Formulation After a Failed BA/BE Study This webinar introduced how IVIVC can be used to get your drug program back on…Danielle Pillsbury2018 年 7 月 18 日